|
HY-112098-5mg
|
MedChemexpress LLC
|
PROTAC ERAlpha Degrader-1 [CAS 2417369-94-7]
|
|
Cancer-programmed cell death
|
|
|
HY-112098-50mg
|
MedChemexpress LLC
|
PROTAC ERAlpha Degrader-1 [CAS 2417369-94-7]
|
|
Cancer-programmed cell death
|
|
|
HY-N7766-1mg
|
MedChemexpress LLC
|
Rubropunctatin [CAS 514-67-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-N7766-2mg
|
MedChemexpress LLC
|
Rubropunctatin [CAS 514-67-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-N7766-5mg
|
MedChemexpress LLC
|
Rubropunctatin [CAS 514-67-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-13749B-100mg
|
MedChemexpress LLC
|
Sitagliptin (phosphate monohydrate) [CAS 654671-77-9]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-13749B-200mg
|
MedChemexpress LLC
|
Sitagliptin (phosphate monohydrate) [CAS 654671-77-9]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-13749B-1mL
|
MedChemexpress LLC
|
Sitagliptin (phosphate monohydrate) [CAS 654671-77-9] (10mM in DMSO)
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-13749A-100mg
|
MedChemexpress LLC
|
Sitagliptin (phosphate) [CAS 654671-78-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-13749A-200mg
|
MedChemexpress LLC
|
Sitagliptin (phosphate) [CAS 654671-78-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-13749A-1mL
|
MedChemexpress LLC
|
Sitagliptin (phosphate) [CAS 654671-78-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-13749-100mg
|
MedChemexpress LLC
|
Sitagliptin [CAS 486460-32-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-13749-200mg
|
MedChemexpress LLC
|
Sitagliptin [CAS 486460-32-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-13749-1mL
|
MedChemexpress LLC
|
Sitagliptin [CAS 486460-32-6] (10mM in DMSO)
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-13749AS-1mg
|
MedChemexpress LLC
|
Sitagliptin-d4 (phosphate) [CAS 1432063-88-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-N1131-10g
|
MedChemexpress LLC
|
Triacetonamine [CAS 826-36-8]
|
|
|
|
|
HY-N1131-25g
|
MedChemexpress LLC
|
Triacetonamine [CAS 826-36-8]
|
|
|
|
|
HY-N1131-1mL
|
MedChemexpress LLC
|
Triacetonamine [CAS 826-36-8] (10mM in DMSO)
|
|
|
|
|
HY-111911-10mg
|
MedChemexpress LLC
|
Xanthocillin X permethyl ether [CAS 4464-33-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-111911-5mg
|
MedChemexpress LLC
|
Xanthocillin X permethyl ether [CAS 4464-33-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-111911-50mg
|
MedChemexpress LLC
|
Xanthocillin X permethyl ether [CAS 4464-33-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-111911-1mL
|
MedChemexpress LLC
|
Xanthocillin X permethyl ether [CAS 4464-33-9] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
ATGP1198-100ug
|
NKMax Bio (ATGen)
|
MGP [20-96 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE, Denatured
|
|
|
ATGP1198-500ug
|
NKMax Bio (ATGen)
|
MGP [20-96 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE, Denatured
|
|
|
GTX10855
|
GeneTex International Corporation
|
BMP1, Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
